Phase Ia pharmacokinetic trial of NKTR 192 in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 02 Apr 2012
At a glance
- Drugs NKTR 192 (Primary)
- Indications Acute pain
- Focus Adverse reactions; Pharmacokinetics
- 02 Apr 2012 Planned number of patients changed to 36, according to a Nektar Therapeutics media release.
- 02 Apr 2012 Status changed from planning to recruiting, according to a Nektar Therapeutics media release.
- 15 Nov 2011 New trial record